Kolli D.

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

Article

Abstract: Background: The multimorbid burden and use of systemic immunosuppressants in people with psoriasis m

Palabras claves:

biologics, covid-19, Hospitalization, immunosuppressants, Psoriasis, RISK FACTORS

Autores:

Aparicio G., Asfour L., Bachelez H., Balogh E.A., Barclay C., Barea A., Barker J.N., Bewley A., Brassard D., Capon F., Cardozo G.A., Carolan J.E., Carras E., Carrascosa J.M., Carugno A., Celine G., Cesar G.A., Choon S.E., Claréus B.W., Coker B., Cummings D., Dand N., Daudén E., Davis C., de Graaf L., De La Cruz C., DeCrescenzo A., Descamps V., Di Meglio P., Dwyer E., Eidsmo L., Enrique Loayza, Essex A., Farida B., Feldman S.R., Freeman E.E., Gisondi P., Greco C., Griffiths C.E.M., Hawryluk E., Hughes J., Jackson K., Johnston G.A., Jones A., Jullien D., Kerisit K.G., King G., Klujszo E., Kolli D., Lambert J., Langan S.M., Lesort C., Mackenzie T., Magnano M., Mahe E., Mahil S.K., Makrygeorgou A., Martinez A., Martínez-García E., Mason K.J., Maybury C., McAteer H., McMahon D.E., Meuleman L., Meynell F., Moorhead L., Morales Callaghan A.M., Mwale A., Naldi L., Ortiz-Salvador J.M., Paolino A., Pearson I., Pérez-Suárez B., Pink A.E., Popov G., Prims C.T., Puig L., Quinlan C., Rech G., Rivera R., Romero-Maté A., Rossi M.T., Ruiz-Genao D., Schwartz J.J., Sergeant A., Shah A., Singapore A., Skov L., Smith C.H., Sonkoly E., Spuls P., Toni E., Tsakok T., Valenzuela F., van Huizen A., Warren R.B., Weisman J., Wu K., Yanguas I., Yiu Z.Z.N.

Fuentes:

google

scopus